Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

2.1K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.1K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

4.1K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunometabolic remodeling of perivascular adipose tissue in murine lupus: implications for lupus vasculopathy.

bioRxiv : the preprint server for biology·2026
Same author

A longitudinal atlas of human psoriatic skin reveals the mechanisms of anti-IL-23 therapy in disrupting the type 17 inflammatory circuit.

Immunity·2026
Same author

Multicytokine-based transcriptome-wide association study for 7 inflammatory skin disorders identifies candidate causal genes in keratinocytes.

The Journal of allergy and clinical immunology·2026
Same author

Whole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial.

Annals of the rheumatic diseases·2026
Same author

Defective Trophoblast Differentiation, Endothelial Dysfunction, and Immune Dysregulation in Preeclampsia Coalesce on a Placental VGLL3-Centered Gene Network.

Circulation·2026
Same author

Disease context dictates the cellular targets of IL-17 in inflammatory skin disease.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Sep 4, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

211

Recent advances in cutaneous lupus.

Mitra P Maz1, Jacob W S Martens1, Andrew Hannoudi2

  • 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, USA; Program in Immunology, University of Michigan, Ann Arbor, MI, 48109, USA.

Journal of Autoimmunity
|July 20, 2022
PubMed
Summary
This summary is machine-generated.

Cutaneous lupus erythematosus (CLE) involves skin inflammation, often triggered by UV light. Understanding its causes, like type I interferon (IFN) in skin cells, reveals new therapeutic targets for this autoimmune condition.

Keywords:
Cutaneous lupusInterferonsPhotosensitivitySkin

More Related Videos

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

192
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K

Related Experiment Videos

Last Updated: Sep 4, 2025

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

211
Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

192
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.9K

Area of Science:

  • Dermatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Cutaneous lupus erythematosus (CLE) is an autoimmune skin condition linked to systemic lupus erythematosus (SLE) or as an isolated entity.
  • UV light exposure frequently triggers CLE flares, impacting patient quality of life and potentially causing systemic inflammation.
  • Recent advancements in understanding CLE pathogenesis offer promising therapeutic targets.

Purpose of the Study:

  • To review the cellular and molecular mechanisms driving CLE initiation and progression.
  • To highlight the role of type I interferon (IFN) and immune cell infiltration in CLE pathogenesis.
  • To discuss potential novel therapeutic strategies based on current etiological understanding.

Main Methods:

  • Comprehensive literature review of CLE etiopathogenesis.
  • Analysis of immune cell populations and cytokine profiles in lesional and non-lesional skin.
  • Examination of the role of epidermal dysfunction and IFN signaling in disease development.

Main Results:

  • CLE development involves a pro-inflammatory epidermis, with excess type I IFN production leading to cell death and cytokine release post-UV exposure.
  • Non-lesional skin in SLE patients shows innate immune cell infiltration and IFN-driven pro-inflammatory cytokine release.
  • Specific immune cells, including IFN-educated T cells and potentially B cells, play crucial roles in CLE lesion development and subtype heterogeneity.

Conclusions:

  • Excessive type I IFN signaling in the skin is a key factor in CLE pathogenesis.
  • Understanding the interplay of tissue-specific and immune cells provides insights into disease propagation.
  • Further research into CLE heterogeneity and immune cell contributions will identify new therapeutic targets.